Navigation Links
Female Blood Donor Concern May Be Unfounded

No link between women's plasma, rare lung condition, study finds

TUESDAY, Oct. 23 (HealthDay News) -- Blood plasma donated by females may not be as dangerous as believed, says a team who question a proposed policy change that would limit the use of plasma from female donors due to the risk of a rare but potentially serious lung condition called transfusion-related acute lung injury (TRALI).

Plasma -- the liquid portion of blood that's separated from red blood cells after a person donated blood -- from females has been implicated as a cause of TRALI, a condition where the lungs fill with fluid. TRALI occurs in an estimated 1 in 1,300 transfusions to 1 in 5,000 transfusions and is the leading cause of transfusion-related death in the United States.

Because of the suspected link between female plasma and TRALI, blood banks in the United States are considering limiting the use of female plasma. Since 2004, the United Kingdom has used only plasma from male donors.

In the study, a team from Duke University Medical Center in Durham, N.C., analyzed 8,300 heart surgery patients. They found no association between transfused female plasma and any harmful outcomes. In fact, the researchers found that patients who received only female plasma had a significant fewer complications.

The findings were presented at the annual meeting of the American Association of Blood Bankers.

"Our data showed no deleterious effect associated with female plasma transfusion, and even pointed toward the possibility of a protective effect," Duke anesthesiologist Dr. Ian Welsby said in a prepared statement.

"TRALI is important, and effective preventive steps should be taken to prevent it; however, we believe that more prospective data needs to be evaluated prior to enacting a policy such as the one in the United Kingdom," Welsby said.

"The bottom line is that female donor plasma may not be as harmful as it has been made out to be, and antibodies from female plasma are only one source of TRALI."

More information

The American Cancer Society has more about possible blood product transfusion risks.

-- Robert Preidt

SOURCE: Duke University, news release, Oct. 22, 2007

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New dimension in the treatment of female sexual dysfunction
2. Genetic differences found between Male and Female brains
3. ZYDUS enters female health care segment
4. Vitamin E supports Female Hearts
5. Sensitive cough suffered by females
6. Myth of female impotence created to boost sales
7. Female Smokers More Prone To Lung Cancer
8. The Success Rate Of Angioplasty In Female Patients Low
9. FDA Diminish Hopes On ‘Female Viagra
10. Have You Ever Wondered Why Male And Female Voices Differ?
11. Female Twins Have More To Share Than Just The Similarity: Risk Of Early Menopause
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
Breaking Medicine Technology: